Summary
- Current Price
- As of today, LKFT price is $30.01, up +1.39% on
- Current Price All-Time High
- LKFT price is currently -89.05% below its historical high of $274.03 set on
- Market Cap
- LKFT current market cap is $2B, down -2.73% year-over-year
- PE Ratio
- LKFT current PE ratio is 3.47
- Revenue
- LKFT current annual revenue is $1.26B, up +320.99% year-over-year
- Next Earnings
- The next earnings release for LKFT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Lakefront Biotherapeutics NV |
| Ticker | NASDAQ: LKFT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Belgium |
| IPO | |
| Indexes | Not included |
| Website | lakefrontbio.com |
| Employees | 452 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $30.01 | |
| Price, 1D Change | +1.39% | |
| $2B | ||
| - | ||
| 3.47 | ||
| 0.61 | ||
| $1B | ||
| Revenue, 1Y Change | +320.99% | |
| $5.50 | ||
| EPS, 1Y Change | +351.91% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | GLPG | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $5.50 | ||
| EPS Estimate | N/A | -$13.24 |
| EPS Est. Change | N/A | -340.94% |
| $1.26B | ||
| Revenue Estimate | N/A | $14.24M |
| Revenue Est. Change | N/A | -98.87% |
| Current Price | $30.01 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $1.22 | - | |
| - | $5.50 | - | |
| -$13.24 | N/A | -340.94% | |
| -$1.72 | N/A | -131.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $298.17M | - | |
| - | $1.26B | - | |
| $14.24M | N/A | -98.87% | |
| $46.09M | N/A | -96.33% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $30.01 | |
| $31.21 | ||
| $28.62 | ||
| $30.20 | ||
| $29.27 | ||
| $0.34 | ||
| 0.61 | ||
| $0.58 | ||
| 57.09 | ||
| 15.29% | ||
| 29.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.26B | ||
| $5.50 | ||
| $1.16B | ||
| 92.66% | ||
| $530.05M | ||
| 42.23% | ||
| $360.57M | ||
| 28.72% | ||
| $588.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 20.11 | ||
| 19.96 | ||
| - | ||
| 6 | ||
| 7.75 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 3.47 | ||
| 1.62 | ||
| 0.52 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $3.80B | ||
| $3.52B | ||
| $4.00B | ||
| $3.61B | ||
| $200.42M | ||
| $179.53M | ||
| $8.12M | ||
| $2.03M | ||
| $77.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $894.69M | ||
| $633.13M | ||
| $92.08M | ||
| $173.16M | ||
| $63.06M | ||
| $0.00 | ||
| -$21.02M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$222.34M | ||
| $257.73M | ||
| -$3.69M | ||
| $15.64M | ||
| -$237.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with LKFT
FAQ
What is the ticker symbol for Lakefront Biotherapeutics NV?
The ticker symbol for Lakefront Biotherapeutics NV is NASDAQ:LKFT
Does Lakefront Biotherapeutics NV pay dividends?
No, Lakefront Biotherapeutics NV does not pay dividends
What sector is Lakefront Biotherapeutics NV in?
Lakefront Biotherapeutics NV is in the Healthcare sector
What industry is Lakefront Biotherapeutics NV in?
Lakefront Biotherapeutics NV is in the Biotechnology industry
What country is Lakefront Biotherapeutics NV based in?
Lakefront Biotherapeutics NV is headquartered in Belgium
When did Lakefront Biotherapeutics NV go public?
Lakefront Biotherapeutics NV initial public offering (IPO) was on May 5, 2005
Is Lakefront Biotherapeutics NV in the S&P 500?
No, Lakefront Biotherapeutics NV is not included in the S&P 500 index
Is Lakefront Biotherapeutics NV in the NASDAQ 100?
No, Lakefront Biotherapeutics NV is not included in the NASDAQ 100 index
Is Lakefront Biotherapeutics NV in the Dow Jones?
No, Lakefront Biotherapeutics NV is not included in the Dow Jones index
When was Lakefront Biotherapeutics NV last earnings report?
Lakefront Biotherapeutics NV's most recent earnings report was on May 6, 2026
When does Lakefront Biotherapeutics NV report earnings?
The next expected earnings date for Lakefront Biotherapeutics NV is August 10, 2026
Data Sources & References
- LKFT Official Website lakefrontbio.com
- LKFT Profile on Yahoo Finance finance.yahoo.com/quote/LKFT
- LKFT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lkft